A Kennewick company may help take care of the potential global shortage of medical isotopes.
Advanced Medical Isotope Corp. plans to test and develop prototype compact devices next week to produce isotopes including molybdenum-99 that are normally produced in a nuclear reactor, Jim Katzaroff, the company's chief executive officer, said Friday.
The Kennewick company was mentioned in a recent New York Times story on the shortage of medical isotopes because of the closure of two aging nuclear reactors in Canada and Holland that provide the bulk of the world's supply of medical isotopes.
Medical isotopes are radioactive substances used in tiny quantities for diagnostic imaging and treatment of various diseases including cancer.
Katzaroff said next week's test of the compact devices will be at Idaho State University in Pocatello, noting that computer simulations for the test have been going on for two years. It's a collaboration between Advanced Medical Isotope, the University of Missouri and a publicly traded company that he declined to identify.
Katzaroff said the Kennewick facility produces another type of diagnostic isotope.
Next week's tests involves shooting a beam into a light-enriched uranium solution, he said.
It'll show the economic feasibility of producing sufficient quantities of molybdenum-99, most commonly used to produce technetium-99m, which is used in about 80 percent to 85 percent of the world's diagnostic imaging procedures.
"If everything goes OK, we hope to be in production in three years," Katzaroff said.
Advanced Medical Isotope's production system is expected to be cheaper and quicker, compared with isotope production in a traditional reactor, he said.
Medical isotopes support about 20 million clinical procedures annually in the U.S., but more than 90 percent of the isotopes are imported.
According to projections by the National Academy of Sciences, the U.S. requires at least 5,000 curies of molybdenum-99 each week to meet current demand, which is expected to grow.
The U.S. isotope supply is vulnerable because the federal government doesn't have an advanced reactor energy policy and program, said Carl Holder, nuclear consultant and a member of Citizens for Medical Isotopes, a local nonprofit group working to promote the national production of medical isotopes.
Most U.S. research money on advanced reactors is spent abroad in France, Russia and China. It's drying up talent in America, Holder said.
"This crisis of medical isotopes has been on the horizon for years," said Carl Cadwell, a Kennewick businessman who has invested in Advanced Medical Isotopes. It's about helping improve people's health, said Cadwell, who also owns Cadwell Laboratories and the Tri-City Court Club.
The company can fulfill a critical need using the talent and existing research facilities in the Tri-Cities, Cadwell said.
Similar stories:
Medical isotope company forms new joint venture
Medical isotope company forms new joint venture
Advanced Medical Isotopes Corp. in Kennewick has formed a joint venture with Spivak Management Inc. and Mann Healthcare Partners Inc. to develop and execute its business strategy.
Advanced Medical Isotopes Corp., or AMIC, produces and distributes medical isotopes for medical diagnostic and treatment use.
Spivak will provide consulting services for five years and Mann Healthcare will provide consulting services for three years.
Cadwell Laboratories expanding, could hire 20
Cadwell Laboratories expanding, could hire 20
Cadwell Laboratories has started construction on an expansion that will allow it to soon hire up to 20 additional employees.
The company, which designs, manufactures and sells medical equipment, is adding a new $1.6 million two-story building that will be connected by a glassed-in walkway to its current building at 909 N. Kellogg St. in Kennewick.
The new glass-fronted building for research and development will include new laboratory and office space, allowing the company to expand all its departments, said Jay Cadwell, projects manager.
Community copes with 2,000 Hanford layoffs
Community copes with 2,000 Hanford layoffs
Editor's note: Hanford started this year with 12,000 workers and nine months later about 2,000 positions have been cut. Herald reporters and photographers take a closer look at what this means to Tri-Citians and our economy with a daily series of stories that begins today.
The day after the last of almost 2,000 workers were told they were losing their jobs at Hanford, Twigs Bistro and Martini Bar opened at the Columbia Center mall in Kennewick.
Business has been excellent, said general manager Will Willingham. Customers have been filling its 267 seats, with waits of up to 30 minutes on some nights.
Mike Fox, supporter of nuclear issues, dies
Mike Fox, supporter of nuclear issues, dies
Mike Fox, known for his outspoken support of nuclear issues and questioning the existence of human-caused global warming, died Friday.
Fox, 74, was in hospice care in Seattle after fighting cancer for several years.
Fox was a retired Hanford nuclear reservation chemist who lived in Richland until recently and spoke about the nuclear causes he believed in on behalf of the Eastern Washington Section of the American Nuclear Society and Citizens for Medical Isotopes. He addressed the Columbia Basin Badger Club as a global warming skeptic.
FFTF's irradiated fuel treatment done
FFTF's irradiated fuel treatment done
Idaho National Laboratory has completed treating irradiated fuel from Hanford's Fast Flux Test Facility, except for some fuel that will be saved for research.
The fuel was shipped to Idaho because the national lab has experience treating fuel bonded with sodium. It had a similar reactor, the Experimental Breeder Reactor-II, another "fast" reactor. The Hanford and Idaho reactors used sodium for cooling.
Idaho National Laboratory's Materials and Fuels Complex was built next to the Experimental Breeder Reactor-ll to safely handle and treat its spent fuel in an argon atmosphere to eliminate the risk of sodium reactions.
Print
Email Story
